Anurima Patra
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Anurima Patra has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
Aditi Chandra
Department of Radiology, Tata Medical Center, Kolkata, West Bengal, India
2 shared publications- Anisha Gehani
Department of Radiology, Tata Medical Center, Kolkata, West Bengal, India
2 shared publications Argha Chatterjee
Department of Radiology, Tata Medical Center, Kolkata, West Bengal, India
2 shared publications- Dayananda Lingegowda
Department of Radiology, Tata Medical Center, Kolkata, West Bengal, India
2 shared publications - Priya Ghosh
Department of Radiology, Tata Medical Center, Kolkata, West Bengal, India
2 shared publications - Saugata Sen
Department of Radiology, Tata Medical Center, Kolkata, West Bengal, India
2 shared publications
Latest Publications
- Open Access
- 5 June 2026
- Published by Georg Thieme Verlag KG in Indian Journal of Radiology and Imaging
Percutaneous Ablation of Renal Masses: A Single-Centre Experience
The aim of this study was to analyze the outcomes of percutaneous ablation in patients with renal masses. We retrospectively analyzed 49 renal tumor ablations performed at our institute between 2019 and 2024. All patients underwent biopsy followed by computed tomography–guided ablation under general anesthesia. Of the 49 patients, 33 were male and 16 were female, with a mean age of 61 years. Biopsy revealed clear cell renal cell carcinoma (RCC) in 34 patients (69.4%) and non-clear cell RCC in 5 patients (10.2%). In 10 patients (20.4%), the biopsy results were inconclusive. The mean tumor size was 2.5 cm. Four patients (8.2%) had tumors larger than 4 cm. Microwave ablation was used in 39 patients (79.6%), radiofrequency ablation (RFA) in 9 patients (18.3%), and 1 patient underwent combined embolization with RFA. The mean follow-up duration was 25 months. Local recurrence occurred in three patients (6.1%), who were subsequently treated with stereotactic body radiotherapy, surgery, or systemic therapy. A complete response was achieved in 46 patients (93.8%). Three patients died within 1 year of follow-up due to non-oncological causes; all had shown a complete response. At the time of the last follow-up, 46 out of 49 patients were alive. Percutaneous ablation using microwave or radiofrequency techniques is a viable alternative to surgery for the treatment of cT1 RCC, with excellent outcomes and a very low cancer-related mortality rate.
- 5 June 2026
- Published by Georg Thieme Verlag KG in Indian Journal of Radiology and Imaging
Open AccessPercutaneous Ablation of Renal Masses: A Single-Centre Experience
The aim of this study was to analyze the outcomes of percutaneous ablation in patients with renal masses. We retrospectively analyzed 49 renal tumor ablations performed at our institute between 2019 and 2024. All patients underwent biopsy followed by computed tomography–guided ablation under general anesthesia. Of the 49 patients, 33 were male and 16 were female, with a mean age of 61 years. Biopsy revealed clear cell renal cell carcinoma (RCC) in 34 patients (69.4%) and non-clear cell RCC in 5 patients (10.2%). In 10 patients (20.4%), the biopsy results were inconclusive. The mean tumor size was 2.5 cm. Four patients (8.2%) had tumors larger than 4 cm. Microwave ablation was used in 39 patients (79.6%), radiofrequency ablation (RFA) in 9 patients (18.3%), and 1 patient underwent combined embolization with RFA. The mean follow-up duration was 25 months. Local recurrence occurred in three patients (6.1%), who were subsequently treated with stereotactic body radiotherapy, surgery, or systemic therapy. A complete response was achieved in 46 patients (93.8%). Three patients died within 1 year of follow-up due to non-oncological causes; all had shown a complete response. At the time of the last follow-up, 46 out of 49 patients were alive. Percutaneous ablation using microwave or radiofrequency techniques is a viable alternative to surgery for the treatment of cT1 RCC, with excellent outcomes and a very low cancer-related mortality rate.
- Open Access
- 4 June 2025
- Published by Georg Thieme Verlag KG in Indian Journal of Radiology and Imaging
- Vol. 36 (01) , 084-091
CT-Guided Percutaneous Core Needle Biopsy of Small Pulmonary Nodules (< 2 cm): How Efficient is it as a Diagnostic Tool in Ruling Out Metastatic Disease?
Incidentally detected small pulmonary nodules in patients with an underlying malignancy most often warrant sampling. Biopsy from such small pulmonary nodules (< 2 cm) is challenging. In this study, we aim to evaluate the accuracy of computed tomography (CT)-guided percutaneous core needle biopsy (CNB) of small pulmonary nodules. A total of 169 patients who had CT-guided percutaneous CNB for small pulmonary nodules (less than 2 cm) between January 2015 and December 2018 were the subjects of this retrospective, single-center investigation. We determined the success rate of CNB and the rate of a diagnostic biopsy. Calculations were made for a multivariate study of the risk variables for complications, such as pneumothorax and pulmonary hemorrhage. The success rate of lung biopsy, defined by obtaining a sample of pathologically reportable quality, was 92.9% (157/169). A malignancy was diagnosed in 60.4% of cases (102/169). Pneumothorax developed in 21.9% cases (37/169), with only 5.3% (9/169) patients requiring treatment (8 needle aspirations and 1 pigtail catheter drainage). Use of a thicker (18G) biopsy needle was the only statistically significant predictor of pneumothorax (odds ratio 2.61, 95% confidence interval 1.24–5.51, p = 0.01). Perifocal hemorrhage was common (72.2%, 122/169) but clinically significant pulmonary lobar hemorrhage was seen only in 6.5% of the cases (11/169). One patient required intensive care unit admission due to desaturation from aspiration of blood. CT-guided biopsy of small pulmonary nodules is safe and feasible with a good success rate.
- 4 June 2025
- Published by Georg Thieme Verlag KG in Indian Journal of Radiology and Imaging
- Vol. 36 (01) , 084-091
Open AccessCT-Guided Percutaneous Core Needle Biopsy of Small Pulmonary Nodules (< 2 cm): How Efficient is it as a Diagnostic Tool in Ruling Out Metastatic Disease?
Incidentally detected small pulmonary nodules in patients with an underlying malignancy most often warrant sampling. Biopsy from such small pulmonary nodules (< 2 cm) is challenging. In this study, we aim to evaluate the accuracy of computed tomography (CT)-guided percutaneous core needle biopsy (CNB) of small pulmonary nodules. A total of 169 patients who had CT-guided percutaneous CNB for small pulmonary nodules (less than 2 cm) between January 2015 and December 2018 were the subjects of this retrospective, single-center investigation. We determined the success rate of CNB and the rate of a diagnostic biopsy. Calculations were made for a multivariate study of the risk variables for complications, such as pneumothorax and pulmonary hemorrhage. The success rate of lung biopsy, defined by obtaining a sample of pathologically reportable quality, was 92.9% (157/169). A malignancy was diagnosed in 60.4% of cases (102/169). Pneumothorax developed in 21.9% cases (37/169), with only 5.3% (9/169) patients requiring treatment (8 needle aspirations and 1 pigtail catheter drainage). Use of a thicker (18G) biopsy needle was the only statistically significant predictor of pneumothorax (odds ratio 2.61, 95% confidence interval 1.24–5.51, p = 0.01). Perifocal hemorrhage was common (72.2%, 122/169) but clinically significant pulmonary lobar hemorrhage was seen only in 6.5% of the cases (11/169). One patient required intensive care unit admission due to desaturation from aspiration of blood. CT-guided biopsy of small pulmonary nodules is safe and feasible with a good success rate.
- Open Access
- 27 March 2025
- Published by Georg Thieme Verlag KG in Indian Journal of Radiology and Imaging
- Vol. 35 (4) , 516-528
CT-Guided Percutaneous Lung Biopsy: Important Steps with “Tips and Tricks” for Optimal Yield
Tissue diagnosis plays a major role in the management of patients with lung lesions, especially if malignancy is suspected. Computed tomography-guided biopsy of lung lesions is a well-established procedure. We share a few “tips and tricks” to keep the procedure safe and comfortable to the patient with optimal yield.
- 27 March 2025
- Published by Georg Thieme Verlag KG in Indian Journal of Radiology and Imaging
- Vol. 35 (4) , 516-528
Open AccessCT-Guided Percutaneous Lung Biopsy: Important Steps with “Tips and Tricks” for Optimal Yield
Tissue diagnosis plays a major role in the management of patients with lung lesions, especially if malignancy is suspected. Computed tomography-guided biopsy of lung lesions is a well-established procedure. We share a few “tips and tricks” to keep the procedure safe and comfortable to the patient with optimal yield.
- 1 January 2022
- Published by Radiological Society of North America (RSNA) in Radiology: Imaging Cancer
- Vol. 4 (1) , e210081
Radiomics for Detection of Pancreas Adenocarcinoma on CT Scans: Impact of Biliary Stents
- 1 January 2022
- Published by Radiological Society of North America (RSNA) in Radiology: Imaging Cancer
- Vol. 4 (1) , e210081
Radiomics for Detection of Pancreas Adenocarcinoma on CT Scans: Impact of Biliary Stents